The productivity of Felix Grant's information searches has risen a thousand-fold with new software
Using a novel combination of maths and text software, Felix Grant has made it easier to explore the uncertainties of alternative energy policy
First observed in the waters of a Scottish canal, solitary waves, or solitons, have applications right across physics, Ray Girvan discovers
Computing in the life sciences used to be about gene and protein sequences; now researchers are adopting a systems approach, reports Clare Sansom
Recording research data electronically sounds like a good idea; but, Peter Rees asks, can you produce that information in court 50 years later?
In different disciplines and across companies of different sizes, Tom Wilkie finds convergent trends of integration and interoperability that will shape scientific computing
John Murphy profiles a pioneer of geographical information systems
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
